Industrial perspective in ocular drug delivery
Y Ali, K Lehmussaari - Advanced drug delivery reviews, 2006 - Elsevier
In the development of a commercial drug product, the formulator must consider various
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
Industrial perspective in ocular drug delivery.
Y Ali, K Lehmussaari - Advanced Drug Delivery Reviews, 2006 - europepmc.org
In the development of a commercial drug product, the formulator must consider various
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
Industrial perspective in ocular drug delivery
Y Ali, K Lehmussaari - Advanced drug delivery reviews, 2006 - pubmed.ncbi.nlm.nih.gov
In the development of a commercial drug product, the formulator must consider various
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
[引用][C] Industrial perspective in ocular drug delivery
Y ALI, K LEHMUSSAARI - Advanced drug delivery reviews, 2006 - pascal-francis.inist.fr
Industrial perspective in ocular drug delivery CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
[引用][C] Industrial perspective in ocular drug delivery
Y Ali, K Lehmussaari - Advanced Drug Delivery Reviews, 2006 - cir.nii.ac.jp
Industrial perspective in ocular drug delivery
Y Ali, K Lehmussaari - Advanced Drug Delivery Reviews, 2006 - infona.pl
In the development of a commercial drug product, the formulator must consider various
perspectives. The bioavailability of the active drug substance is often the major hurdle to …
perspectives. The bioavailability of the active drug substance is often the major hurdle to …